Quinazoline derivative and application thereof
- 申请号:US201214241067
- 专利类型:US
- 申请(专利权)人:中国科学院福建物质结构研究所
- 公开(公开)号:US9193718(B2)
- 公开(公开)日:2015.11.24
- 法律状态:
- 出售价格: 面议 立即咨询
专利详情
专利名称 | Quinazoline derivative and application thereof | ||
申请号 | US201214241067 | 专利类型 | US |
公开(公告)号 | US9193718(B2) | 公开(授权)日 | 2015.11.24 |
申请(专利权)人 | 中国科学院福建物质结构研究所 | 发明(设计)人 | Lu Canzhong;Yong Jianping |
主分类号 | A61K31/517 | IPC主分类号 | A61K31/517;C07D413/12;C07D413/06 |
专利有效期 | Quinazoline derivative and application thereof 至Quinazoline derivative and application thereof | 法律状态 | |
说明书摘要 | This invention provides a class of quinazoline compounds, as represented by formula (I), and their pharmaceutically acceptable salts,;wherein: each of R1 and R2 independently, is selected from H, C1-C6 alkoxy, halo-C1-C6 alkoxy, C1-C6-alkoxy-C1-C6 alkoxy, C3-C8 cycloalkoxy, C3-C8 heterocycloalkoxy containing at least one of heteroatoms selected from N, O, S; Z is —NR4—, C(R5)2, S or —O—, wherein R4 is H or C1-C3 alkyl, R5 is the same or different, selected from H or C1-C3 alkyl; R3 is selected from H, halogen, C1-C6 alkyl, C1-C6 alkoxy or halo-C1-C6 alkyl; n is an integer from 0 to 5. This invention also provides methods of preparation and medical uses of the compounds of formula (I) and their pharmaceutically acceptable salts. These compounds have the activity of inhibiting EGFR-TK, and can be used as drugs for the treatment of protein tyrosine kinase related diseases such as tumors, cancers, etc. |
交易流程
-
01
选取所需
专利 -
02
确认专利
可交易 - 03 签订合同
- 04 上报材料
-
05
确认变更
成功 - 06 支付尾款
- 07 交付证书
过户资料
平台保障
1、源头对接,价格透明
2、平台验证,实名审核
3、合同监控,代办手续
4、专员跟进,交易保障
- 用户留言
暂时还没有用户留言